Logo

Incyte Reports Decreased Q3 Revenues, Widened Losses

Nov 04, 2003

NEW YORK, Nov. 4 (GenomeWeb News) - Incyte today reported significantly decreased third-quarter revenues, and widened net losses.

 

The Palo Alto, Calif., company reported revenues of $13.2 million for the third quarter, compared to $22.4 million for the same period last year. Net loss widened to $43.0 million, from $38.4 million for the third quarter of 2002.

 

R&D expenses were down to $28.6 million, from $47.4 million in the third quarter of 2002.

 

As of Sept. 30, Incyte had $315.1 million in cash and cash equivalents.

Breaking News
The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.